Member Info for Muck165

I think the best thrust of the piece is recognition that we have "got in on the ground" with Salignostics, being experts in Saliva as a testing medium and a company that could therefore revolutionise the self testing landscape across multiple use cases. If Salistick works, and becomes mainstream, then doors begin to really open up....

Couple that with the more general need to bring medical diagnosis into the home rather than overburdened national health services and surgeries and well, the market potential is massive.

Https://investingstrategy.co.uk/stock-tips/abingdon-health-shares-another-biotech-stock-to-watch/

From the last interims, to 31/12/22

"The Company's cash balance at 31 December 2022 was £4.4m and is expected to be £3.7m at 31 March 2023. We also anticipate our adjusted EBITDA loss to reduce in H2 2023 compared to H2 2022 due to increased sales and the cost reductions made. The Group produces outward forecasts over a period of at least 12 months which are sensitised to reflect the companies expected cash position under various trading circumstances and believes that it has operating headroom for at least this length of time."

So we shouldn't need to have a placing, and we have to remember that the Directors are major shareholders and so it will affect them just as it would affect us. If demand is what we think it should be for Salistick, then it only further reduces the risk of any placing. But even then, I'm not worried if they CHOOSE to do a placing - I can't see it being for much or at any significant discount, and it will put the company on an even better footing to make the most of the various opportunities it has.

For those unaware, Salignostics updated their site to add a company called Addeira as a distributor on their site 6-8 weeks ago, in just the same way ABDX is listed there as a distributor. Addeira service the Nordic region, and this was posted today confirming launch of Salistick

https://www.mynewsdesk.com/se/addeira/pressreleases/addeira-pharmaceuticals-ab-introducerar-salistick-ett-banbrytande-salivbaserat-graviditetstest-som-revolutionerar-graviditetstestning-3259387?utm_source=rss&utm_medium=rss&utm_campaign=Alert&utm_content=pressrelease

In English it begins

“ Addeira is proud to announce the launch of SaliStick, a rapid and advanced saliva-based pregnancy test.”

https://www.addeira.co/salistick

Abdx launch won’t be long…!

"1" trade at 16.24.

Someone having a laugh I suspect, and personally don't buy the myth anyway.....

But you never know...

Exciting period coming up whatever.

I was told by the company that they are officially launching this week.

Can’t really see that happening Friday, so either tomorrow or Thursday is my bet.

If it does launch this week then is it a coincidence that it coincides with this?

https://www.linkedin.com/feed/update/urn:li:activity:7064517424166924288/

There will be plenty of potential CDMO customers at the event, and what better way to promote our services than to be able to point to the launch of a worlds first product by one of our existing CDMO clients.

Just called the company.

They confirmed that they "are officially launching this week"

They said Salistick would not likely be available to buy from their site for another couple of weeks.

I asked if it might be possible to buy it from anywhere else - they said they "weren't allowed to say" if you would be able to buy it from retail stores

So this completely backs up what Liquidsilver was told.

Agree suedee5! Can't really understand why anyone would sell now unless they are concerned that the delay owes to some problem with the test quality?

I suppose that's a possibility but not really one I buy - I just think ABDX are getting all of their ducks in a row and we will get an RNS detailing the launch and distribution channel(s), hopefully to include Amazon and Superdrug and that coupled with that, we will see stories about the launch in mainstream media as well as across social media.

Https://www.linkedin.com/showcase/abingdon-simply-test/posts/?feedView=all

Interesting their posting on a Sunday evening though..

We’ve had stuff on Amazon for a while….

Again - sounds great. Was it from the company LS?

“starting with an exclusive national brand channel” might explain the Superdrug web page. Always wondered why Lloyds pharmacy but only in Ireland not the whole of the U.K. Perhaps Superdrug we’re always in the running and our preferred partner for the U.K?

When I called the company at the beginning of May they were certainly indicating launch at the end of May, but formally they have always said by the end of Q2.

Its what I suggested as one reason for the "delay" yesterday.

SD were on my "hope for" list, so it would be wonderful if we did have them on board and even better if they were to stock it in their retail outlets.

It would be news to me.....

May be nothing this

I did a google search for Salistick entries over the last week, and this page popped up

https://www.superdrug.com/salistick/b/418352

Currently says "0 products found", nor does anything come up just by using the Superdrug search tool for "Salistick" or "Pregnancy Tests". So like I say, maybe nothing!

But then you have to wonder why Superdrug appear to be showing a page on their site with our product.....

Is he legally able to issue placing stock without a GM vote raising the limits? Don't think so, hence the GM

The premise of the GM seems sound, ie lets put ourselves in a position to show lenders we have options.

We might get another small extension off the back of it.

But personally I think this is looking more like a placing, and a big one. If that happens then the extent of any placing discount will better help us all understand the true prospect re the diamonds.

Can't think Capstone are too happy either.

@fortnefvtsbrve - interesting comment about “ongoing commercial discussions”. Could I suppose mean lots of things, but the one that springs to my mind first is the prospect that someone is negotiating to buy a lot of the current stock leaving little for anyone else…

Patience is key - can’t imagine there’s much of a problem if our head of R&D is putting articles out like this a couple of days ago.

https://www.femtechworld.co.uk/insight/womens-health-diagnostics-a-market-in-the-midst-of-transformation-abi23/